SCHEMBL24325822

SCHEMBL24325822

Cc1cccc(-c2nc(CCN3C(=O)c4ccccc4C3=O)cs2)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.78
SMN1; SMN2 Q16637 3/20 0.78
L3MBTL1 Q9Y468 2/20 0.76
RXFP1 Q9HBX9 1/20 0.76
ALDH1A1 P00352 4/20 0.66
HPGD P15428 2/20 0.66
PKM P14618 1/20 0.64
POLB P06746 3/20 0.57
MAPT P10636 8/20 0.56
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.56
TP53 P04637 6/20 0.53
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
CYP2D6 P10635 1/20 0.51
KDM4E B2RXH2 2/20 0.50
RAB9A P51151 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23027807 0.88 LMNA (1.00) LMNASMN1; SMN2L3MBTL1RXFP1ALDH1A1
SCHEMBL23027822 0.86 LMNA (0.83) LMNASMN1; SMN2L3MBTL1RXFP1ALDH1A1
SCHEMBL23027810 0.86 SMN1; SMN2 (1.00) LMNASMN1; SMN2L3MBTL1RXFP1ALDH1A1
SCHEMBL23027798 0.84 LMNA (0.78) LMNASMN1; SMN2L3MBTL1RXFP1ALDH1A1
SCHEMBL23027811 0.80 LMNA (1.00) LMNASMN1; SMN2L3MBTL1RXFP1ALDH1A1
SCHEMBL23027787 0.75 POLB (0.84) LMNASMN1; SMN2L3MBTL1RXFP1ALDH1A1
SCHEMBL23027794 0.75 LMNA (0.65) LMNASMN1; SMN2L3MBTL1RXFP1ALDH1A1
SCHEMBL23027836 0.74 LMNA (0.61) LMNASMN1; SMN2L3MBTL1RXFP1ALDH1A1
SCHEMBL17261495 0.74 PKM (0.72) LMNASMN1; SMN2L3MBTL1RXFP1ALDH1A1
SCHEMBL29451720 0.73 PKM (0.70) LMNASMN1; SMN2L3MBTL1RXFP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3960171-A1 USE OF ADAM9 INHIBITOR AS IMMUNOMODULATOR China Medical University (TW) 2022-03-02 EP disclosed